To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Harmony Biosciences secures $200 mln debt facility
OrbiMed Advisors has provided a $200 million debt facility to Plymouth Meeting, Pennsylvania-based Harmony Biosciences LLC, a pharmaceutical company focused on treating people living with rare diseases.
